{"id":"W2294823670","doi":"10.1038/bcj.2016.9","title":"Lenalidomide treatment and prognostic markers in relapsed or refractory chronic lymphocytic leukemia: data from the prospective, multicenter phase-II CLL-009 trial","year":2016,"lang":"en","type":"article","venue":"Blood Cancer Journal","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"Deutsche Forschungsgemeinschaft; National Cancer Institute; Celgene","keywords":"IGHV@; Lenalidomide; Internal medicine; Chronic lymphocytic leukemia; Oncology; Medicine; Refractory (planetary science); Hematology; Fludarabine; Gastroenterology; Leukemia; Multiple myeloma; Chemotherapy; Biology; Cyclophosphamide","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009138196,0.0003883053,0.0006520601,0.0001498581,0.0003056011,0.0001055152,0.0005573305,0.0001909168,0.000963516],"category_scores_gemma":[0.001189549,0.0001806024,0.0001198487,0.0002614279,0.0002803425,0.0003199627,0.0003207843,0.0005238347,0.0000244666],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.09279612,"about_ca_system_score_gemma":0.05678612,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003612234,"about_ca_topic_score_gemma":0.002839667,"domain_scores_codex":[0.9965872,0.0003356284,0.0007931038,0.000770865,0.0007119919,0.0008012458],"domain_scores_gemma":[0.9967255,0.00136202,0.0003288111,0.001058318,0.0001377338,0.0003876247],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7035703,0.003449431,0.01746671,0.0002343647,0.004996321,0.00509036,0.001920545,0.00003979436,0.01867199,0.000009848119,0.01531419,0.2292362],"study_design_scores_gemma":[0.9612621,0.01189777,0.0041218,0.00232411,0.001417016,0.001203629,0.0002057935,0.004560988,0.002178955,0.00004032299,0.01044448,0.0003430368],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9846783,0.010928,0.00001966078,0.001184229,0.0005319534,0.002322755,0.000170996,0.00003742798,0.0001267081],"genre_scores_gemma":[0.9829667,0.01210033,0.0001557084,0.0002063117,0.002678652,0.0002815541,0.00002359767,0.00007206082,0.001515063],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2576918,"threshold_uncertainty_score":0.9999498,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05766062988039832,"score_gpt":0.3618330372027641,"score_spread":0.3041724073223657,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}